Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank100
3Y CAGR+111.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+111.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
9.5x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.95M | +9.3% |
| 2024 | $14.59M | +14.4% |
| 2023 | $12.76M | +659.5% |
| 2022 | $1.68M | +346.0% |
| 2021 | $-683000.00 | -41.4% |
| 2020 | $-483000.00 | - |